AU2001284454A1 - Method of screening antitumor agent by using interaction between arf protein and hk33 protein - Google Patents

Method of screening antitumor agent by using interaction between arf protein and hk33 protein

Info

Publication number
AU2001284454A1
AU2001284454A1 AU2001284454A AU8445401A AU2001284454A1 AU 2001284454 A1 AU2001284454 A1 AU 2001284454A1 AU 2001284454 A AU2001284454 A AU 2001284454A AU 8445401 A AU8445401 A AU 8445401A AU 2001284454 A1 AU2001284454 A1 AU 2001284454A1
Authority
AU
Australia
Prior art keywords
protein
interaction
antitumor agent
arf
screening antitumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284454A
Inventor
Sunil C. Kaul
Takashi Sugihara
Renu Wadhwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Research Institute for Molecular Medicine Inc
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
Chugai Research Institute for Molecular Medicine Inc
National Institute of Advanced Industrial Science and Technology AIST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Research Institute for Molecular Medicine Inc, National Institute of Advanced Industrial Science and Technology AIST filed Critical Chugai Research Institute for Molecular Medicine Inc
Publication of AU2001284454A1 publication Critical patent/AU2001284454A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
AU2001284454A 2000-09-08 2001-09-06 Method of screening antitumor agent by using interaction between arf protein and hk33 protein Abandoned AU2001284454A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-274209 2000-09-08
JP2000274209 2000-09-08
PCT/JP2001/007732 WO2002020770A1 (en) 2000-09-08 2001-09-06 Method of screening antitumor agent by using interaction between arf protein and hk33 protein

Publications (1)

Publication Number Publication Date
AU2001284454A1 true AU2001284454A1 (en) 2002-03-22

Family

ID=18760004

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284454A Abandoned AU2001284454A1 (en) 2000-09-08 2001-09-06 Method of screening antitumor agent by using interaction between arf protein and hk33 protein

Country Status (3)

Country Link
JP (1) JPWO2002020770A1 (en)
AU (1) AU2001284454A1 (en)
WO (1) WO2002020770A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003087395A2 (en) * 2002-04-15 2003-10-23 Inserm Methods to identify anti-tumoral agents inhibiting rasgap / aurora kinase interactions
AU2003243627A1 (en) 2002-06-18 2003-12-31 Ingersoll-Rand Energy Systems Corporation Microturbine engine system
US7625716B2 (en) 2003-11-26 2009-12-01 Vanderbilt University Methods for assessing p19-Arf interactions in cMyc
US20060094059A1 (en) * 2004-09-22 2006-05-04 Odyssey Thera, Inc. Methods for identifying new drug leads and new therapeutic uses for known drugs
JP2009052942A (en) * 2007-08-24 2009-03-12 Konica Minolta Holdings Inc Screening method of signal transmission regulating agent
US8765370B2 (en) * 2009-06-11 2014-07-01 Scinopharm Taiwan, Ltd Inhibition-based high-throughput screen strategy for cell clones
CN105238833B (en) * 2014-06-20 2021-01-15 浙江海洋学院 Application of bullacta oligopeptide in resisting prostatic cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127158A (en) * 1994-12-07 2000-10-03 President And Fellows Of Harvard College Ubiquitin conjugating enzymes

Also Published As

Publication number Publication date
WO2002020770A1 (en) 2002-03-14
JPWO2002020770A1 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
AU2001245928A1 (en) Electrolyzer and method of using the same
AU2001294175A1 (en) Method of purifying antibody
AUPR785001A0 (en) Tamponade apparatus and method of using same
AU2002353979A1 (en) Environmentally resistant block and method of using same
AU2001257638A1 (en) Co-located frequency-agile system and method
AU2001257075A1 (en) Screen and method of making the same
AU2001238696A1 (en) Method of reducing defects
AU2001292867A1 (en) Ligands for g protein coupled receptors and methods of using them
AU2002353612A1 (en) System and method of international patent application
AU2002230606A1 (en) Glazing unit and method of making the same
AU2002319790A1 (en) Particulate addition method and apparatus
AU2001253772A1 (en) System and methods for the high throughput screening of polymorphs
AU2002220036A1 (en) Method and system for improving stability of photomasks
AU2002251186A1 (en) Loudspeaker and method of making same
AU2001284454A1 (en) Method of screening antitumor agent by using interaction between arf protein and hk33 protein
AU2002342672A1 (en) Method for screening for inhibitors of protein/protein interaction and corresponding ribozymes
AU2001294258A1 (en) Method of purifying plavastatin
AU2002318925A1 (en) Multi-colored materials and method of making same
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2001288519A1 (en) Substractive metallization structure and method of making
AUPR857301A0 (en) Printing elements and methods of construction
AU2001253491A1 (en) Masking apparatus and method
AU7579600A (en) Method of producing and purifying endostatintm protein
AU2000259049A1 (en) Histidyl-proline diketopiperazine and method of use
AU2001265402A1 (en) Sequential high throughput screening method and system